Table 2.
Feature | Adults (18 years+) with severe asthma
|
Children (6–17 years) with severe asthma
|
||
---|---|---|---|---|
Observation {versus nonsevere asthma) | Reference | Observation (versus nonsevere asthma) | Reference | |
Exacerbation severity | Frequency emergency department visits and hospitalizations with ~30% hospitalized in the previous year; 20–25% with lifetime history of intubation | [3] | Frequent emergency department visits and hospitalizations with ~55% hospitalization in the previous year; 10–15% with lifetime history of intubation | [2,42] |
| ||||
Allergic sensitization | Varying degrees of atopy according to age of asthma onset and phenotype cluster | [3,20▪▪] | Highly atopic with increased peripheral blood eosinophilia, aeroallergen sensitivity, and elevated serum IgE concentrations | [2,42.44▪▪] |
| ||||
Exhaled nitric oxide | Not distinguishing overall but associated with exacerbations in a selected phenotype | [3,45▪] | Sustained elevations | [2] |
| ||||
Airflow limitation | Moderate-to-severe airflow limitation, often with incomplete reversal after bronchodilation | [3,20▪▪,46] | Some (mild) airflow limitation with near-complete reversal after bronchodilation; significant acceleration of airflow limitation in some adolescents after puberty | [2,42,48▪▪] |
| ||||
Air trapping | Increased air trapping (increased RV/TLC) at the same threshold of airflow limitation (FEV1/FVC) | [46] | Increased air trapping (increased RV/TLC) at baseline; reversible in girls but persistent in boys | [2,47▪▪] |
FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; RV/TLC, ratio of residual volume to total lung capacity.